Sodium Alendronate: Treatment for Osteoporosis and Bone Loss
Sodium Alendronate is a medication from the bisphosphonate group, which acts as a potent inhibitor of bone resorption (bone tissue breakdown). It helps restore the balance between bone formation and destruction.
The drug selectively accumulates at sites of active bone recovery and suppresses the activity of osteoclasts — cells that break down bone tissue. This leads to a significant increase in bone mineral density and substantially reduces the risk of spinal and hip fractures.
Alendronate is considered the gold standard for treating osteoporosis in postmenopausal women and in men.
Indications
- Postmenopausal Osteoporosis: Treatment and prevention of fractures, including spinal and hip fractures.
- Osteoporosis in Men: To increase bone mass and prevent fractures.
- Glucocorticoid-Induced Osteoporosis: Treatment of bone loss in patients taking long-term hormonal medications (steroids).
- Paget's Disease: Treatment of bone deformities and pain caused by this condition.
Dosage and administration
The effectiveness of the drug directly depends on strict adherence to the administration rules. Failure to follow instructions can lead to serious esophageal irritation.
- Standard dose: Usually prescribed as 10 mg daily or 70 mg once weekly.
- How to take: Immediately upon waking up, at least 30 minutes before the first intake of food, beverages, or other medications.
- To wash down: Only with a full glass of plain water (no mineral water, juice, or coffee).
- Body position: Do not lie down after taking the medication. You must remain in an upright position (standing or sitting) for at least 30 minutes until your first meal is consumed.
- Abnormalities of the esophagus which delay esophageal emptying (e.g., strictures or achalasia).
- Inability to stand or sit upright for at least 30 minutes.
- Low blood calcium levels (hypocalcemia).
- Severe renal impairment.
- Pregnancy and breastfeeding period.
When taken correctly, the drug is usually well-tolerated, but the following reactions may occur:
- Digestive system: Heartburn, abdominal pain, difficulty swallowing, or esophageal ulcers (if administration rules are violated).
- Musculoskeletal: Pain in bones, joints, or muscles (sometimes severe).
- General symptoms: Headache, bloating, constipation, or diarrhea.
- Rare effects: Osteonecrosis of the jaw (usually associated with tooth extraction during therapy) and atypical hip fractures.
